Health

ZEISS Presents New Surgical Workflow Innovations at ASCRS

New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows. JENA, Germany and DUBLIN, Calif., May 3, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Su...

2023-05-03 02:09 2521

Turacoz Forges Ahead with Veeva Content Certification & Training for Professionals

UTRECHT, Netherlands and NEW DELHI, May 3, 2023 /PRNewswire/ -- Turacoz Healthcare Solutions has been making strides in the field of medical communications using cutting-edge technologies. The demand for high-quality scientific and medical writing is increasing, and Turacoz is leading the way in ...

2023-05-03 01:55 2654

Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a reduction of proteinuria that was sustained through 108 weeks of treatment S...

2023-05-03 00:22 3295

iHerb Names Miriee Chang as Chief Operating Officer

Newly established role will further streamline operations and enhance operational effectiveness IRVINE, Calif., May 3, 2023 /PRNewswire/ -- iHerb Holdings, LLC, announced that Miriee Chang has been named its Chief Operating Officer (COO). Mrs. Chang brings significant leadership experience to th...

2023-05-03 00:14 2847

Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis

* First patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). * Ongoing Phase 1/1b study evaluating safety and efficacy of CK0803. HOUSTON, May 3, 2023 /PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic...

2023-05-03 00:07 1993

China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award

HANGZHOU, China, May 2, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that the Co...

2023-05-02 20:30 3254

AvantGuard Applauded by Frost & Sullivan for Extending the Life of Chlorine-based Disinfectants for Sustained Efficacy with Its Residual Antimicrobial Solutions

The residual antimicrobial solutions provide continuous efficacy, minimize the frequent antimicrobial dosage on surfaces, and reduce operational costs and time in the healthcare and food and beverage industries. SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the Nort...

2023-05-02 20:00 1960

Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne

HANGZHOU and SHAOXING, China, May 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that ASC40 (Denifanstat), a first-in-class, once-daily oral fatty acid synthase (FASN) inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acn...

2023-05-02 17:30 3136

Grand and People's Choice Stevie® Award Winners Announced in 2023 Asia-Pacific Stevie Awards

Cisco Systems Named Organization of the Year; More Than 9,300 Were Cast in the Public Vote FAIRFAX, Va., May 2, 2023 /PRNewswire/ -- The Stevie® Awards, organizer of the world's premier business awards programs, announced the winners of five Grand Stevie Award trophies, plus nine winners of a Pe...

2023-05-02 15:37 2525

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

* Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations * Customers will have simpler and greater access to industry-leading expertise, tools, and services AMERSHAM, United Kingdom, May 2, 2023 /PRNewswire/ -- Cytiva and the life scienc...

2023-05-02 12:01 3443

First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide

MELBOURNE, Australia, May 2, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged inCanada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for i...

2023-05-02 05:00 2244

Mintal Tracker Honored as Bronze Stevie® Award Winner in 2023 American Business Awards®

Mintal Tracker was recognized for providing users with an easy way to achieve healthier sleep SAN FRANCISCO, May 1, 2023 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers a scientific approach to healthier sleep, was named the winn...

2023-05-01 23:00 1590

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

New survey by Health Canal reveals that personal health and safety concerns drive older adults' intentions and attitudes toward bivalent booster shots GROVE CITY, Ohio, May 1, 2023 /PRNewswire/ -- The CDC has recommended the bivalent mRNA COVID-19 vaccines sinceSep...

2023-05-01 22:00 1922

Meihua International Medical Technologies Co., Ltd.'s Subsidiary Completes Purchase of Land Use Right of Nearly 50,000 Square Meters in Hainan Free Trade Port Boao Hope City for the Construction of Integrated Medical Industrial Park

YANGZHOU, China, May 1, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company, via ...

2023-05-01 20:30 3742

The Clinician to participate at Digital Health Festival 2023 in Melbourne

MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- The Clinician , a global healthcare company redefining how care is measured and delivered, announced that they will be participating in the 2023 Digital Health Festival inMelbourne on the 6-7 June, 2023. Digital Hea...

2023-05-01 20:00 2510

I-MAB Filed 2022 Annual Report on Form 20-F

GAITHERSBURG, Md. and SHANGHAI, May 1, 2023 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it has filed its annual report on Form 20...

2023-05-01 20:00 2101

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary ar...

2023-05-01 18:30 2795

Zimmer Biomet Announces Acquisition of OSSIS

SINGAPORE, May 1, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as wel...

2023-05-01 12:00 5142

GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date – – Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innova...

2023-05-01 11:00 3152

ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller

MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalT...

2023-05-01 08:58 2645
1 ... 233234235236237238239 ... 848